Abstract:Objective To investigate the clinical efficacy of the treatment of long-term non-invasive positive pressure ventilation (NIPPV) combined with inhaling corticosteroids in patients with stable chronic o0bstructive pulmonary disease(COPD) complicated with respiratory failure,and to investigate the impact of longterm NIPPV combined with inhaling corticosteroids on serum levels of matrix metalloproteinase-9 (MMP-9).Methods Eighty outpatients of stable severe COPD complicated with respiratory failure divided them equally into two treatment groups (the experimental and the control groups).The two groups of patients were given oxygen therapy,inhalation of Salmeterol and fluticasone propionate powder for one year.The experimental group received additionally NIPPV therapy for 1 year.The outcomes measured included St.George's questionnaire (SGRQ) score,MMRC score,6-min working time (6-MWT),arterial partial pressure of oxygen (PaO2),partial pressure of carbon dioxide(PaCO2),Forced expiratory volume in 1 (FEV1％),and the serum levels of MMP-9 before and after treatment,and frequency of acute exacerbations of COPD and hospital says in the last one year and the following 12 months.Results After 1 year,the differences of SGRQ score,MMRC score,6-MWT,PaO2,PaCO2,FEV1％,MMP-9 in the experimental group ((63.38 ±4.46) vs.(52.93 ±4.30),t =10.67,P =0.00;(3.60±0.50) vs.(2.40 ±0.50),t =10.82,P=0.00;(159.90 ±6.50) m vs.(247.10±9.66) m,t=47.39,P=0.00;(56.85 ± 1.67) mm Hg vs.(66.10 ±2.59) mm Hg,t =10.67,P =0.00;(60.38 ±3.58)mm Hgvs.(51.88 ±3.05)mm Hg,t=10.82,P=0.00; (38.93 ±3.22)％ vs.(42.12 ±3.11)％,t=47.39,P =0.00;(182.58 ±6.60) μg/L vs.(171.73 ±6.19) μg/L,t =7.58,P =0.00) were statistically significant compared to the control group ((63.88 ± 4.88) vs.(54.30 ± 4.13),t =8.77,P =0.00; (3.65 ± 0.48) vs.(2.70±0.46),t =8.97,P =0.00;(157.98 ±5.97) m vs.(218.08±13.12) m,t =26.38,P=0.00;(56.65 ±1.51)mm Hg vs.(62.60 ± 1.91)mm Hg,t=8.77,P=0.00; (60.20 ±3.52)mm Hg vs.(56.25 ±3.09)mm Hg,t =8.97,P =0.00; (38.93 ±2.96) ％ vs.(40.70 ±3.27)％,t =26.38,P =0.00; (180.55 ±4.78) μg/L vs.(173.05 ± 5.28) μg/L,t =6.66,P =0.00).The frequency of acute exacerbations of COPD and hospital stay days were significantly decreased in the experimental group than in the control group.Conclusion Long-term NIPPV combined with inhaling corticosteroids could significantly improve the quality of life and lower the serum levels of MMP-9 of patients with severe stable COPD complicated with respiratory failure. Key words: Chronic obstructive pulmonary disease; Respiratory failure; Non-invasive positive pressure ventilation; Corticosteroids; Matrix metalloproteinase-9

Therapeutic Effects of BiPAP Ventilator in COPD with Type II Respiratory Failure Through 56 Patients

An Approach to the Treatment of Noninvasive Bilevel Positive Airway Pressure(BiPAP) Ventilation in COPD Patients with Type-Ⅱ Respiratory Failure(RF).

The Comparison Between the Continual Positive Airway Pressure Ventilation and the Bilevel Positive Airway Pressure Ventilation in Treating Acute Cardiogenic Pulmonary Edema

The use of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema

Efficacy of Non-invasive Bi-level Positive Airway Pressure Ventilation in the Patients with Type Ⅱ Respiratory Failure due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Therapeutic effect of ipratropium bromide combined with long-term domiciliary oxygen therapy for patients with chronic obstructive pulmonary disease

The Effect of Bi-level Positive Airway Pressure Non-invasive Ventilation on the Treatment of Acute Left Ventricular Failure

Clinical Efficacy of Non-invasive Mechanical Ventilation with BiPAP Ventilator on COPD with Tape Ⅱ Respiratory Failure

The value of mechanical ventilation therapy for patients with severe acute left heart failure

Effect of Noninvasive Bi-Level Positive Airway Pressure Ventilation on Treatment of Acute Left Heart Failure Complicated with Respiratory Failure by Titration of Pressure

Efficacy of noninvasive ventilator treatment in patients with severe chronic obstructive pulmonary disease (COPD) type II respiratory failure

Therapeutic Effect Observation of BiPAP Respirator Treating Chronic Obstructive Pulmonary Disease Complicated with Pulmonary Encephalopathy

Efficacy and Impact on Serum Matrix Metalloproteinase-9 of Long-Term Non-Invasive Positive Pressure Ventilation Combined with Inhaling Corticosteroids in Patients with Stable Severe Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Non-invasive Positive Pressure Ventilation Reduces the Rate of Re-Intubation in Pediatric Patients after Cardiac Surgery

Clinical Application Noninvasive Positive Pressure Ventilation in Chronic Obstructive Pulmonary Disease with Pulmonary Encephalopathy

Observation on the Effect of Non-Invasive Ventilator Combined with Conventional Therapy in the Treatment of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Evaluation of Noninvasive Bi-level Positive Airway Pressure Ventilation in Treatment of Elderly Patients with Heart Failure

A Clinical Analysis on the BiPAP Ventilator in Treatment of COPD with Sleep Apnea Syndromes

The Value of BiPAP Respirator in Managing Acute Cardiac Failure after Cardiac Surgery

Bi-level Positive-Pressure Non-invasive Ventilation on Treatment of Acute Left Ventricular Failure

Efficacy of noninvasive positive pressure ventilation in the treatment of acute bronchial asthma with respiratory failure